We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.
Medtech Insight is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183
Advanced BioHealing (cell-based and tissue engineered products for wound healing) raised $25.5mm through its Series C round that was led by Safeguard Scientifics. Channel Medical Partners, Red Abbey Venture Partners, Canaan Partners, and Wheatley Partners also participated. ABH will put the funds towards the recent launch of its diabetic foot ulcer product Dermagraft, which the company bought from Smith & Nephew last year.
Deal Industry
Medical Devices
Medical Devices
Biomaterials
Biotechnology
Gene Therapy, Cell Therapy
Deal Status
Final
Deal Type
Financing
Venture Financing
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?